scholarly journals Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling

2017 ◽  
Vol 152 (8) ◽  
pp. 2022-2036 ◽  
Author(s):  
Bin Chen ◽  
Wei Wei ◽  
Li Ma ◽  
Bin Yang ◽  
Ryan M. Gill ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cell Division ◽  
Cell Division Cycle ◽  
Carcinoma Cells ◽  
Drug Candidate ◽  
Hepatocellular Carcinoma Cells ◽  
Computational Discovery

Identification ofPFTAIREprotein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells

Hepatology ◽  
2007 ◽  
Vol 46 (2) ◽  
pp. 436-445 ◽  
Author(s):  
Etonia Y-T. Pang ◽  
Alfa H-C. Bai ◽  
Ka-Fai To ◽  
Shirley M-H. Sy ◽  
Navy L-Y. Wong ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cell Division ◽  
Cell Division Cycle ◽  
Carcinoma Cells ◽  
Related Gene ◽  
Hepatocellular Carcinoma Cells

scholarly journals Retraction: MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions

RSC Advances ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 4439-4439
Author(s):  
Laura Fisher
Keyword(s):  
Hepatocellular Carcinoma ◽  
Carcinoma Cells ◽  
Gene Expressions ◽  
Hepatocellular Carcinoma Cells ◽  
Ctnnb1 Gene

Retraction of ‘MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions’ by Qiang He et al., RSC Adv., 2019, 9, 1717–1725, DOI: 10.1039/C8RA09229J

scholarly journals CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo

2017 ◽  
Vol 37 (6) ◽  
pp. 3565-3571 ◽  
Author(s):  
Xiaoli Wang ◽  
Wenmei Zhang ◽  
Yan Ding ◽  
Xingrong Guo ◽  
Yahong Yuan ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Genome Engineering ◽  
Carcinoma Cells ◽  
Hepatocellular Carcinoma Cells
Sign in / Sign up

Export Citation Format

Share Document